| Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer. | ovarian, |
| N-myc oncogene amplification and prognostic factors of neuroblastoma in children. | neuroblastoma, |
| A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer. | colorectal, |
| Flow cytometric quantitation of the c-myc oncoprotein in archival neoplastic biopsies of the colon. | colorectal, |
| Noncorrelation of the expression of the c-myc oncogene in colorectal carcinoma with recurrence of disease or patient survival. | colorectal, |
| In vivo amplification and rearrangement of c-myc oncogene in human breast tumors. | breast, |
| Surgical aspects of N-myc oncogene amplification of neuroblastoma. | neuroblastoma, |
| Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus. | neuroblastoma, |
| Rearrangement and enhanced expression of c-myc oncogene in fresh tumor cells obtained from a patient with acute lymphoblastic leukemia. | leukemia, |
| A transfected c-myc oncogene inhibits mouse erythroleukemic differentiation. | leukemia, |
| Amplification of the c-myc oncogene is associated with an abnormally banded region on chromosome 8 or double minute chromosomes in two HL-60 human leukemia sublines. | leukemia, |
| Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. | lymphoma, |
| Interleukin-1 stimulates thyroid cell growth and increases the concentration of the c-myc proto-oncogene mRNA in thyroid follicular cells in culture. | thyroid, |
| Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor beta in a human breast carcinoma cell line. | breast, |
| Expression of the c-myc proto-oncogene in growth stimulated porcine thyroid follicle cells. | thyroid, |
| Detection of the c-myc oncogene product in colonic polyps and carcinomas. | colorectal, |
| The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry. | lymphoma, |
| Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. | uterine, |
| Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma. | neuroblastoma, |
| Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator. | neuroblastoma, |